219 related articles for article (PubMed ID: 37822991)
21. N-Hydroxysuccinamide functionalized iron oxide nanoparticles conjugated with 5-flurouracil for hyperthermic therapy of malignant liver cancer cells by DNA repair disruption.
Veeramani S; Chandrababu L; Rajangam I; Singh NR; Al-Humaid L; Al-Dahmash ND; Balaji R; Chandrasekar N; Hwang MT
Int J Biol Macromol; 2023 Oct; 250():126001. PubMed ID: 37532190
[TBL] [Abstract][Full Text] [Related]
22. Preparation and Characterization of Fe
Dai X; Yao J; Zhong Y; Li Y; Lu Q; Zhang Y; Tian X; Guo Z; Bai T
Int J Nanomedicine; 2019; 14():9647-9663. PubMed ID: 31824157
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
[TBL] [Abstract][Full Text] [Related]
24. MUC1 Aptamer-Capped Mesoporous Silica Nanoparticles for Navitoclax Resistance Overcoming in Triple-Negative Breast Cancer.
Vivo-Llorca G; Candela-Noguera V; Alfonso M; García-Fernández A; Orzáez M; Sancenón F; Martínez-Máñez R
Chemistry; 2020 Dec; 26(69):16318-16327. PubMed ID: 32735063
[TBL] [Abstract][Full Text] [Related]
25. Optimization of the Preparation of Magnetic Liposomes for the Combined Use of Magnetic Hyperthermia and Photothermia in Dual Magneto-Photothermal Cancer Therapy.
T S A; Lu YJ; Chen JP
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707876
[TBL] [Abstract][Full Text] [Related]
26. Novel Antibodies Targeting MUC1-C Showed Anti-Metastasis and Growth-Inhibitory Effects on Human Breast Cancer Cells.
Kim MJ; Choi JR; Tae N; Wi TM; Kim KM; Kim DH; Lee ES
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380650
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and characterization of monodispersed water dispersible Fe
Sharma KS; Ningthoujam RS; Dubey AK; Chattopadhyay A; Phapale S; Juluri RR; Mukherjee S; Tewari R; Shetake NG; Pandey BN; Vatsa RK
Sci Rep; 2018 Oct; 8(1):14766. PubMed ID: 30283083
[TBL] [Abstract][Full Text] [Related]
28. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells.
Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A
Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421
[TBL] [Abstract][Full Text] [Related]
29. Enhanced cellular uptake of LHRH-conjugated PEG-coated magnetite nanoparticles for specific targeting of triple negative breast cancer cells.
Hu J; Obayemi JD; Malatesta K; Košmrlj A; Soboyejo WO
Mater Sci Eng C Mater Biol Appl; 2018 Jul; 88():32-45. PubMed ID: 29636136
[TBL] [Abstract][Full Text] [Related]
30. [A method of showing thermal effect of iron oxide nanoparticles in alternating magnetic field].
Liu X; Xu B; Xia QS; Zhao TD; Tang JT
Ai Zheng; 2005 Sep; 24(9):1148-50. PubMed ID: 16159444
[TBL] [Abstract][Full Text] [Related]
31. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
Hasegawa M; Takahashi H; Rajabi H; Alam M; Suzuki Y; Yin L; Tagde A; Maeda T; Hiraki M; Sukhatme VP; Kufe D
Oncotarget; 2016 Mar; 7(11):11756-69. PubMed ID: 26930718
[TBL] [Abstract][Full Text] [Related]
32. Immuno-hyperthermia effected by antibody-conjugated nanoparticles selectively targets and eradicates individual cancer cells.
Kagawa T; Matsumi Y; Aono H; Ohara T; Tazawa H; Shigeyasu K; Yano S; Takeda S; Komatsu Y; Hoffman RM; Fujiwara T; Kishimoto H
Cell Cycle; 2021 Jul; 20(13):1221-1230. PubMed ID: 34148497
[TBL] [Abstract][Full Text] [Related]
33. MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
Goode G; Gunda V; Chaika NV; Purohit V; Yu F; Singh PK
PLoS One; 2017; 12(5):e0176820. PubMed ID: 28464016
[TBL] [Abstract][Full Text] [Related]
34. Construction of small-sized superparamagnetic Janus nanoparticles and their application in cancer combined chemotherapy and magnetic hyperthermia.
Xie L; Jin W; Zuo X; Ji S; Nan W; Chen H; Gao S; Zhang Q
Biomater Sci; 2020 Mar; 8(5):1431-1441. PubMed ID: 31960005
[TBL] [Abstract][Full Text] [Related]
35. Improving the Efficacy of Magnetic Nanoparticle-Mediated Hyperthermia Using Trapezoidal Pulsed Electromagnetic Fields as an In Vitro Anticancer Treatment in Melanoma and Glioblastoma Multiforme Cell Lines.
Souiade L; Domingo-Diez J; Alcaide C; Gámez B; Gámez L; Ramos M; Serrano Olmedo JJ
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958913
[TBL] [Abstract][Full Text] [Related]
36. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
37. Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression.
Yamashita N; Kufe D
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897789
[TBL] [Abstract][Full Text] [Related]
38. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
39. MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment.
Zou Q; Zhang CJ; Yan YZ; Min ZJ; Li CS
J Cell Biochem; 2019 Nov; 120(11):18650-18658. PubMed ID: 31338877
[TBL] [Abstract][Full Text] [Related]
40. CD44-Targeted Magnetic Nanoparticles Kill Head And Neck Squamous Cell Carcinoma Stem Cells In An Alternating Magnetic Field.
Su Z; Liu D; Chen L; Zhang J; Ru L; Chen Z; Gao Z; Wang X
Int J Nanomedicine; 2019; 14():7549-7560. PubMed ID: 31571863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
